Currently, no permits can be issued for the import of cannabis for medical purposes into Germany. The Federal Institute for Drugs and Medical Devices (BfArM) confirmed this in response to an inquiry from krautinvest.de. The reason is that the current demand estimate for cannabis for medical purposes in Germany, as reported to the International Narcotics Control Board (INCB) for the current calendar year, is 122 tons. This has already been exhausted. However, the authority stated that there will be no import ban. However, processing times for applications could be extended.
The BfArM further states that the complex procedure for the annual demand estimates for narcotic drugs results in international legal requirements “to generally set demand estimates restrictively.” Excessive demand estimates could lead to significant cuts by the INCB. However, the BfArM offers some reassurance: To ease the situation, it has the instrument of the so-called ‘re-estimation’ during a current calendar year. This, it states, “only extends the processing times of an application for import authorization in individual cases until the new quantity is confirmed by the INCB.” The BfArM did not disclose which “new quantity” is to be confirmed, nor how far this process has progressed. However, a speaker emphasizes: “As a rule, there is no halt to imports or formal rejection of applications for import authorizations.” The BfArM does not specify how long the processing times might be.
According to federal authorities, the cannabis quota reported to the INCB refers only to medical cannabis flowers; extracts are to be considered separately. Information on the current stocks of medical cannabis flowers held by wholesalers and pharmacies in Germany is not available.
Deepak Anand, a long-time cannabis industry expert, emphasizes in a LinkedIn post : “It is important that the INCB does not set any limits or quotas on the amount of ‘narcotic drugs,’ including cannabis, produced worldwide for medical and scientific purposes.” If exports or imports of narcotic drugs such as cannabis exceed the relevant estimates, the council can contact the affected countries and request explanations and corrective measures, Anand explains. For example, an importing country could be asked to explain whether an apparent excess import is intended for re-export, or the country could be advised to submit a supplementary estimate to the council if it requires additional quantities of a narcotic drug such as cannabis over the course of a year, and continues. According to the BfArM, the “issue is currently being clarified.” Since the removal of medical cannabis, the BfArM has no longer published how much medical cannabis has found its way into pharmacies.
Continue at: https://krautinvest.de/genehmigungen-fuer-einfuhr-von-cannabis-pausiert-hoechstmenge-von-122-tonnen-erreicht/
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link
Also see:
Manostaxx – Industrial Management Consulting
